InvestorsHub Logo
Followers 51
Posts 3973
Boards Moderated 0
Alias Born 03/20/2014

Re: DoTheRightThing post# 414259

Monday, 05/08/2023 11:31:00 AM

Monday, May 08, 2023 11:31:00 AM

Post# of 465090
The fact is, there are Super Responders. Along with an excellent safety profile, Blarcamesine is in a different category than the mabs.

They need to be compared so people can see the difference but with the Markets denial Blarcamesine even exists, there is just the B.S. we see here on the boards, non stop.

Truth is, the mabs are garbage and the Market wants to profit from garbage because that’s all it has, so they focus on keeping Anavex out of the spotlight.

The denial at CTAD, statements like “never before seen results,” when talking about Adu, Leq, and Don.

You rig the game, millions, suffer and someone will notice.

Super Responders, more than a few, excellent safety record over eight years in different populations, huge unmet need, ancillary positive side effects, the list goes on. There will be a New Drug Application to the FDA but there are other things happening too.

All my posts are my opinion only and shouldn’t be used for decisions regarding purchasing or selling.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News